Semaglutide 10 mg is a synthetic GLP-1 receptor agonist research compound supplied for laboratory research only. It is an analogue of human GLP-1 and is studied in models of incretin signalling, glucose regulation and appetite control.
Key Aspects of Semaglutide
- Mechanism: Long-acting GLP-1 analogue with high sequence homology to the human hormone, studied for effects on insulin secretion, glucagon suppression and gastric emptying.
- Structure: A modified research compound with a fatty acid side chain that extends its half-life (approximately 7 days) and supports albumin binding.
- Research areas: Glucose homeostasis, appetite signalling and cardiometabolic pathways in laboratory models.
- Format: Lyophilised (freeze-dried) powder, 10 mg per vial.
Regulatory Note
Semaglutide is a prescription-only substance in Australia. This product is supplied for in-vitro and laboratory research only, and nothing on this page is a claim about safety or efficacy in humans.
Storage
Store the lyophilised powder in a cool, dark place, or refrigerate at 2°C to 8°C. Once reconstituted with bacteriostatic water, keep chilled and use within the recommended laboratory timeframe.
For laboratory and research purposes only. Not for human consumption, medical use, or veterinary use.
